🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Gynecologic Cancer

Improve Cancer-related Cognitive Impairment NCT05864274NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: Cognitive training application Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries NCT06816836n/a1 site📍 Kolkata Tata Medical Center · Tests: Bed Side ultrasound guided muscle mass estimation of lower extremity Pilot Observational Study of an Integrative Cure Stay Program NCT07398079n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: Integrative Cure Stay, Matched Control Group Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy NCT04957511n/a1 site📍 Orlando Viome Spatially Fractionated Radiation Treatment for Gynaecological Cancers NCT06644846NA1 site📍 Navi Mumbai Tata Memorial Hospital · Tests: Spatially fractionated radiation therapy Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment NCT05562778NA4 sites📍 Brooklyn📍 New York📍 New York Weill Medical College of Cornell University · Tests: Chatbot Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) NCT05407987Phase 31 site📍 Calgary AHS Cancer Control Alberta · Tests: Ferric derisomaltose, Placebo BOLSTER: Learning New Skills to Thrive NCT06936878NA2 sites📍 Boston📍 Houston Dana-Farber Cancer Institute · Tests: BOLSTER Program Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract NCT05478876NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: carbon ion radiation therapy CIRT Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers NCT07731880n/a1 site📍 Seattle Fred Hutchinson Cancer Center Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy NCT07234968NA2 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Ureteral Stent Placement, No Ureteral Stent, Indocyanine Green with Fluorescence Imaging Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy NCT06997887NA1 site📍 Taipei National Taiwan University Hospital · Tests: CH2 vaginal gel, vaginal rehabilitation exercises A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) NCT05098171EARLY Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Signal Switch Receptor Modified TIL Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies NCT05979610Phase 21 site📍 Salt Lake City University of Utah · Tests: Reiki therapy Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites📍 Anderlecht📍 Ghent📍 Wilrijk European Organisation for Research and Treatment of Cancer … · Tests: Stereotactic body radiotherapy, Palliative RT Advanced Pelvic Surgical Oncology Database - Prospective Observational Study NCT05696002n/a1 site📍 Glasgow Glasgow Royal Infirmary First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors NCT05768139Phase 1, Phase 265 sites📍 Los Angeles📍 San Francisco📍 Aurora Eli Lilly and Company · Tests: STX-478, Fulvestrant, Ribociclib, Palbociclib, Letrozole Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer NCT04530890NA1 site📍 Poitiers Poitiers University Hospital · Tests: Blood samples A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Engineering Tumor Infiltrating Lymphocytes Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients NCT05738252n/a4 sites📍 Hamilton📍 Mississauga📍 Toronto Population Health Research Institute · Tests: Clinical Frailty Scale, Frailty Phenotype Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer. NCT07039526Phase 21 site📍 Dallas John Waters · Tests: CYTALUX™ (pafolacianine) injection preoperatively Retrospective Study of Brachytherapy NCT05242861n/a1 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Brachytherapy Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies NCT07434284EARLY Phase 11 site📍 Shanghai Obstetrics & Gynecology Hospital of Fudan University · Tests: cCTL treatment Avera Cancer Sequencing and Analytics Protocol (ASAP) NCT05142033n/a6 sites📍 Marshall📍 Aberdeen📍 Mitchell Avera McKennan Hospital & University Health Center Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329Phase 11 site📍 New York Brian Henick, MD · Tests: Brodalumab, CT scan Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients NCT07416630NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Web-Based Application for PROM Monitoring During Radiotherapy Predicting Cancer Risk With Digital and Molecular Markers NCT06962670NA1 site📍 Please Refer to Project Homepage For Details (see Link Below) University of Erlangen-Nürnberg Medical School · Tests: Biomaterial collection, BayPass mobile application Gynecologic Extramammary Paget's Disease NCT03564483n/a1 site📍 Rochester Mayo Clinic Vaginal Dilator Therapy After Pelvic Radiation NCT07216456NA1 site📍 Durham Duke University · Tests: Improving Engagement with Vaginal Dilator Therapy after Pelvic Radiation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy